Table 2.
Clinicopathologic characteristics according to Galectin-9 expression level.
| Variable | Gal-9 Expression | p Value | |
|---|---|---|---|
| Low | High | ||
| Age | |||
| <50 years | 11 (50%) | 42 (48.3) | 0.885 |
| ≥50 years | 11 (50%) | 45 (51.7) | |
| pT stage | |||
| T1 | 5 (22.7) | 42 (48.3) | 0.031 |
| T2–3 | 17 (77.3) | 45 (51.7) | |
| pN stage | |||
| N0 | 13 (59.1) | 61 (70.1) | 0.322 |
| N1–3 | 9 (40.9) | 26 (29.9) | |
| Histologic grade | |||
| 1–2 | 6 (27.3) | 19 (21.8) | 0.588 |
| 3 | 16 (72.7) | 68 (78.2) | |
| Ki-67 labeling index | 0.067 | ||
| <20% | 9 (40.9) | 19 (21.8) | |
| ≥20% | 13 (59.1) | 68 (78.2) | |
| Extensive intraductal component | 0.081 | ||
| Absent | 17 (77.3) | 79 (90.8) | |
| Present | 5 (22.7) | 8 (9.2) | |
| Lymphovascular invasion | 0.008 | ||
| Absent | 12 (54.5) | 71 (81.6) | |
| Present | 10 (45.5) | 16 (18.4) | |
| P53 overexpression | 0.270 | ||
| Absent | 7 (31.8) | 39 (44.8) | |
| Present | 15 (68.2) | 48 (55.2) | |